Related Experiment Video
Updated: Jul 5, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha
Aditi Chatterjee1, Sunil Upadhyay, Xiaofei Chang
1Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Abstract:
DeltaNp63alpha, the dominant negative isoform of the p63 family is an essential survival factor in head and neck squamous cell carcinoma. This isoform has been shown to be down regulated in response to several DNA damaging agents, including cisplatin. But little is understood about the post-translational protein stability of DeltaNp63alpha. In this present study we demonstrate for the first time that DeltaNp63alpha physically interacts with U-box-type E4 ubiquitin ligase UFD2a. UFD2a stabilizes DeltaNp63alpha, and ubiquitylation of DeltaNp63alpha is attenuated by UFD2a both in the presence and absence of cisplatin. Ectopic expression of UFD2a increased the half-life of DeltaNp63alpha in association with a significant enhancement of the repressive transcriptional activity of DeltaNp63alpha. Downregulation of endogenous UFD2a by RNAi resulted in degradation of DeltaNp63alpha. Taken together, our current study provides an insight onto the regulation of DeltaNp63alpha protein levels in response to cisplatin and also suggests that UFD2a might play an important role in the regulation of cisplatin mediated cell death mediated by p63.
Insights
The E4 ubiquitin ligase UFD2a stabilizes DeltaNp63alpha, a key survival factor in head and neck cancer. UFD2a regulates DeltaNp63alpha levels and activity, impacting cisplatin-induced cell death.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- DeltaNp63alpha is a critical survival factor in head and neck squamous cell carcinoma.
- DeltaNp63alpha is downregulated by DNA damaging agents like cisplatin.
- The post-translational regulation of DeltaNp63alpha stability is poorly understood.
Purpose of the Study:
- To investigate the interaction between DeltaNp63alpha and UFD2a.
- To elucidate the role of UFD2a in DeltaNp63alpha protein stability and function.
- To understand the regulation of DeltaNp63alpha in response to cisplatin treatment.
Main Methods:
- Co-immunoprecipitation to detect protein interactions.
- Western blotting to assess protein levels and ubiquitylation.
- RNA interference (RNAi) to downregulate UFD2a expression.
- Reporter assays to measure transcriptional activity.
Main Results:
- DeltaNp63alpha physically interacts with UFD2a, a U-box-type E4 ubiquitin ligase.
- UFD2a stabilizes DeltaNp63alpha and attenuates its ubiquitylation, even with cisplatin.
- Ectopic UFD2a expression enhances DeltaNp63alpha's half-life and transcriptional repression.
- RNAi-mediated downregulation of UFD2a leads to DeltaNp63alpha degradation.
Conclusions:
- UFD2a stabilizes DeltaNp63alpha protein levels.
- UFD2a plays a significant role in regulating DeltaNp63alpha stability and activity.
- UFD2a may be crucial in mediating p63-dependent cell death in response to cisplatin.
Related Concept Videos
Abnormal Proliferation
The Unfolded Protein Response
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
